ClinicalTrials.gg
RecruitingNCT07301710Updated Sep 10, 2026

Low-Tech Treatments for Obstructive Sleep Apnea

A Phase 1/2 interventional study of High-Resistance Breathing and Drinking Exercises and Low-Resistance Breathing and Drinking Exercises in Obstructive Sleep Apnea (OSA) and Traumatic Brain Injury (TBI), sponsored by Uniformed Services University of the Health Sciences. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Uniformed Services University of the Health Sciences · Phase 1/2, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Phase
Phase 1/2
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The overall purpose of this study is to compare changes in sleep outcomes in people with obstructive sleep apnea (OSA) depending on their participation in one of two behavioral interventions; both involve drinking water and breathing. A second purpose is to compare outcomes between people who have sustained a traumatic brain injury (TBI) and those with no history of TBI. The main questions it aims to answer are whether sleep quality improves after 3-months of high-resistance versus low-resistance exercises, and whether people have different outcomes depending on their history of TBI.

Read the detailed description

Background

A nonintrusive, inexpensive behavioral approach is emerging as a promising alternative to the management of obstructive sleep apnea (OSA). Generally referred to as myofunctional therapy (MFT), the approach involves exercising the muscles of the oropharynx and respiratory system.The exercises are intended to improve muscle strength and tone so that the muscular structures of the upper airway improve their neuromuscular responsiveness to breathing and resist collapsing into the airway during sleep. They are relatively simple to implement and train, but the regimen requires high-dosage practice and strict dedication to habituate. There is a need for an MFT protocol to be delivered in a consistent manner that is simple, sustainable, and motivating. This study takes advantage of recent low-tech tools that appear to elicit the desired muscle actions achieved with MFT.

Participant Recruitment

Participants are recruited from the Sleep Clinic at Walter Reed National Military Medical Center if they receive a new diagnosis of obstructive sleep apnea (AHI >5) based on standard-of-care polysomnography (PSG) or if they do not successfully use a standard first-line treatment. After providing informed consent and passing screening tests, they are randomized into one of two behavioral interventions.

Interviews will determine whether participants have a history of TBI. Participants in the two intervention arms will be block stratified based on +/- TBI and TBI severity. The groups will also be stratified based on OSA severity.

Interventions

The interventions involving drinking water through a study-provided water bottle with a specially designed nozzle and breathing in and out through a study-provided handheld breathing device multiple times daily for 3 months. Therefore, this novel intervention is called "HydroBreathe Therapy." The intervention arms are named for the color of the breathing device. Participants will be informed that the Green option involves exercises intended to relax airway structures and promote better airway patency, and that the Black option involves high-resistance exercises intended to increase airway muscle strength to resist structural collapse. Participants are not informed which of the options is expected to be more therapeutic, but they are informed that both may help and neither will worsen their OSA.

Participants will enter their daily practice into electronic adherence logs, which will be monitored by the study team. A study team member will contacted participants every 2 weeks throughout the intervention period to offer encouragement and answer questions.

Assessments

Pre- and post-intervention measures are obtained from PSG results, self-assessment questionnaires, and measures of tongue and respiratory muscle function. Participants in the experimental group will be given the option to participate in a 3-week follow-up assessment including the questionnaires and muscle-function testing if they are willing to delay first-line treatment for OSA. All participants will be referred back to the Sleep Clinic for standard treatment at the conclusion of the study.

02

Conditions studied

  • Obstructive Sleep Apnea (OSA)
  • Traumatic Brain Injury (TBI)

Keywords

  • Obstructive Sleep Apnea
  • Myofunctional Therapy
  • Traumatic Brain Injury
  • Randomized Controlled Trial
  • Oropharyngeal Exercises
  • Respiratory Resistance Training
03

In context

Sleep Apnea, Obstructive

2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.

This study's planned enrollment of 60 is above the median of 52 across 1,472 interventional studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Uniformed Services University of the Health Sciences is the lead sponsor of 45 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • New diagnosis of OSA (AHI, ≥ 5) or failure of OSA treatment;
  • Willingness to forego first-line OSA treatment or stop current OSA treatment for 3 months;
  • Ability to follow directions and perform the required exercises;
  • Age between 18-65 yr.

Exclusion criteria

Exclusion Criteria:

  • Current use of OSA treatment;
  • Medical comorbidities that require restricting fluid intake (e.g., dysphagia, renal disease, liver disease, hyponatremia);
  • Severe nasal obstruction; 4) severe ankyloglossia; 4) craniofacial abnormality; 5) severe pulmonary disease; 6) severe post-traumatic stress disorder; 7) very severe insomnia; 8) (BMI) ≥30 kg/m2
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Line of therapy

A line of therapy is one course of treatment, which may combine several drugs. First-line is the first course given; second-line follows when that stops working or is not tolerated.

“Two prior lines” means two courses that count separately under the study’s rules — not simply two drugs. Ask the study team if you are unsure how yours are counted.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Myofunctional Therapy

    Behavioral: High-Resistance Breathing and Drinking Exercises

  • Sham comparator
    Relaxation Therapy

    Behavioral: Low-Resistance Breathing and Drinking Exercises

Interventions

  • BehavioralHigh-Resistance Breathing and Drinking Exercises

    Three months of drinking at least 32-oz of water daily through a high-resistance nozzle, and inhaling and exhaling 60 times per day through a high-resistance breathing device

    Also known as: Device-Assisted Myofunctional Therapy

  • BehavioralLow-Resistance Breathing and Drinking Exercises

    Three months of drinking 32-oz of water daily through a low-resistance nozzle, and inhaling and exhaling 40 times per day through a low-resistance breathing device

    Also known as: Placebo Therapy

06

What researchers measure

Primary outcomes

  1. Apnea-Hypopnea Index (AHI)

    AHI is the number of apneic and hypopneic episodes per hour of sleep. The scores start at zero, meaning no events are taking place. A mild score falls in the range of 5-15; moderate 15-30, and a severe diagnosis is 30 or more events per hour. Pre-intervention AHI is obtained from standard-of-care in-clinic sleep study. Post-intervention AHI is obtained from an in-clinic sleep study conducted as part of this research.

    Time frame: From enrollment to end of three-month intervention

Secondary outcomes

  1. SpO2

    Oxygen saturation measured during the in-clinic sleep studies. Normal levels range between 95-100%.

    Time frame: From enrollment to end of three-month intervention

  2. Snore Index

    Number of snoring episodes per hour of sleep

    Time frame: From enrollment to end of three-month intervention

  3. Epworth Sleepiness Scale (ESS)

    A self-assessment of daytime sleepiness comprising eight questions on a four-point scale (0-3; total range = 0-24). Higher scores indicate greater daytime sleepiness.

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

  4. Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10)

    A self-assessment of the impact of daytime sleepiness on daily activities. Of the 10 questions, five are rated 0-4 and five are rated 1-4, for a total score ranging between 5-40. A higher score indicates lower impact.

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

Other outcomes

  1. Tongue Strength

    The maximum pressure generated during tongue-to-palate compression of an air-filled bulb over three trials.

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

  2. Tongue Endurance

    The maximum duration of sustaining tongue-to-palate compression of an air-filled bulb at 50% of maximum pressure.

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

  3. Maximal Inspiratory Pressure (MIP)

    The maximum pressures generated during maximal-effort inspiration in cmH2O.

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

  4. Maximal Expiratory Pressure (MEP)

    The maximum pressures generated during maximal-effort expiration in cmH2O.

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

07

Study locations

1 of 1 sites recruiting
  • Walter Reed National Military Medical Center
    Bethesda, Maryland 20889, United States
    Recruiting
    • Kathleen M. Moran, Ed.D. · Contactkmoran@genevausa.org · 443-776-1689
    • Nancy P. Solomon, Ph.D. · Principal investigator
    • Kent Werner, MD, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — Per a Data Sharing Agreement, de-identified primary and secondary outcome data from Walter Reed National Military Medical Center will be shared with investigators at Uniformed Services University of the Health Sciences, contractors with the Geneva Foundation, and colleagues at University of Minnesota (UMN). UMN colleagues are conducting a concurrent study using the same procedures as the experimental arm; both sites plan to pool data for a larger sample size.

Supporting information: Study protocol

Time frame: The study protocol was developed during grant-proposal preparation. Investigators communicate regularly to share updates and coordinate procedures for study implementation. IPD will be made available periodically throughtout data-collection and during data analysis and dissemination (anticipated Jan 2026 -- Dec 2028).

Access criteria: The WRNMMC/USUHS research team will share coded data with project-related Geneva Foundation contractors and UMN collaborators. The coded data will be stored on REDCap, housed on an encrypted password- and firewall-protected server. Authorized project personnel may request IPD through the PIs.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07301710
Lead sponsor
Uniformed Services University of the Health Sciences
Responsible party
Sponsor
First posted
Dec 24, 2025
Start date
Jan 29, 2026
Primary completion
Sep 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Sep 10, 2026

Study contacts

Nancy P. Solomon, Ph.D.
Contact
nancy.p.solomon.civ@health.mil
301-319-7042
Kathleen M. Moran, Ed.D
Contact
kmoran@genevausa.org

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion